Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Boehringer Ingelheim Pharma patents new prostanoid DP2 receptor antagonists

Aug. 17, 2012

Roche reports novel bradykinin B1 receptor antagonists

Aug. 17, 2012

GSK develops new RAR-related orphan receptor-gamma modulators

Aug. 17, 2012

New candidate analgesics synthesized at Eli Lilly

Aug. 16, 2012

Curegenix reports new lysophospholipid LPA1 receptor antagonists

Aug. 16, 2012

Novel candidate HIV drugs designed by GlaxoSmithKline

Aug. 16, 2012

Novel RAR-related orphan receptor-gamma modulators developed

Aug. 16, 2012

Novel B-raf inhibitors divulged by Boehringer Ingelheim

Aug. 16, 2012

Nerviano Medical Sciences discloses new protein kinase inhibitors

Aug. 16, 2012

Novartis patents new CDK9/cyclin-T1 inhibitors

Aug. 16, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 12, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026